Viewing Study NCT00240994


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2025-12-26 @ 1:42 AM
Study NCT ID: NCT00240994
Status: COMPLETED
Last Update Posted: 2017-01-02
First Post: 2005-10-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization: